Bapcor Ltd (BAP)
Australian Securities Exchange · Australia · prices in AUD · close of 20 Oct 2026
Key indicators
| Last close | AUD 0.775 |
|---|---|
| 52-week range | 0.355 – 2.675 |
| Return, 1 month / 3 months | −4.3% / +98.7% |
| Return, 1 year / 3 years | −69.8% / −84.9% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 90.6% |
| Worst drawdown (1 year) | -86.3% |
| Average daily value traded | 4.66M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bapcor is an Australian company that supplies parts, accessories and equipment for vehicles through its trade and retail businesses. Its outlets serve mechanics, repair shops and retail customers, offering components for servicing and repairing cars and light commercial vehicles. The company also distributes automotive tools, workshop equipment and related products, and it operates a network of stores and distribution centres across Australia and New Zealand, with some activities in other regions.
On this site Bapcor Ltd appears as a stock on the Australian Securities Exchange (Australia), code BAP, with prices in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bapcor Ltd (BAP) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.775 on 20 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 942 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 69.8% and over the last three months it rose 98.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -4.5% | ||
| From 52-week high | -70.4% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 98.7% | ||
| 6-month return | 38.4% | ||
| 12-month return, skipping the last month | -68.5% | ||
| Stability (higher is calmer) | 19 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 90.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -86.3% | ||
| Liquidity | 87 · Strong | Trades actively. | |
| Average daily value traded | 4.66M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +1.3% |
|---|---|
| 1 month | −4.3% |
| 3 months | +98.7% |
| 6 months | +38.4% |
| 1 year | −69.8% |
| 3 years | −84.9% |
| 5 years | −89.1% |
Signals
| 50-day / 200-day average | 0.716 / 0.811 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.042 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Sep 2025 | AUD 0.0399 |
| 13 Mar 2025 | AUD 0.0580 |
| 29 Aug 2024 | AUD 0.0399 |
| 7 Mar 2024 | AUD 0.0688 |
| 30 Aug 2023 | AUD 0.0833 |
| 27 Feb 2023 | AUD 0.0761 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.